Available Until 10/19/2026
View Cart

New Treatments for Alzheimer’s Disease

Planned in cooperation with the ASHP Section of Clinical Specialists & Scientists/Emerging Sciences SAG 

ACPE Activity Number: 0204-0000-23-161-H01-P
Release Date:  10/19/2023
Expiration Date: 10/19/2026
Activity Type: Knowledge-based 
CE Credits:  1.0 contact hour, (0.10 CEUs)
Activity Fee: Member – Free / Non-Member – Not Available 

This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.

Activity Overview 

Managing patients with Alzheimer’s Disease (AD) focuses primarily on symptom management. However, new disease modifying therapies have entered the market. This presentation will review current treatment options for different AD stages and review new treatments and their place in therapy.  

   
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

This activity was planned to meet the educational needs of pharmacists practicing in hospitals, health systems, clinics, and outpatient facilities especially those who manage elderly patients or patients with Alzheimer disease. 

After completing this activity, the learner should be able to…

  • Define dementia and Alzheimer’s disease (AD) including major pathological hallmarks of AD.
  • Describe the AD continuum and clinical presentation.
  • Discuss current pharmacotherapy options, their treatment goals, and place in AD therapy. 

  • Introduction and Announcements 

  • Presentation  

  • Questions, Answers, and Discussion 

Marketa Marvanova, PharmD, PhD, BCGP, BCPP, FASCP
Dean and Professor
Pacific University School of Pharmacy
Hillsboro, OR 

Moderator

Deanna Moretz, PharmD, BCPS
Clinical Pharmacy Specialist
Oregon State Unversity College of Pharmacy
Portland, OR 

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

  • No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

This activity consists of recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP Learning Center. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity. 

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.